This is the authors' abstract. We don't add key points for this paper.
A new study 1 published in Nature compares the mechanisms used by SARS-CoV-1 and SARS-CoV-2 papain-like protease (PLpro) to promote innate immune evasion. Its findings identify SARS-CoV-2 PLpro as an attractive drug target for treating COVID-19.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
McClain et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: